These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33482681)

  • 21. Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials.
    Brunetti ND; Tricarico L; Correale M; De Gennaro L; Santoro F; Ieva R; Di Biase M
    J Thromb Thrombolysis; 2020 Aug; 50(2):305-310. PubMed ID: 31654194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis.
    Al Yami MS; Silva MA; Donovan JL; Kanaan AO
    J Thromb Thrombolysis; 2018 Jan; 45(1):36-47. PubMed ID: 29043538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-Molecular-Weight Heparin in Cancer Patients: Overview and Indications.
    Voigtlaender M; Langer F
    Hamostaseologie; 2019 Feb; 39(1):67-75. PubMed ID: 30703821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of venous thromboembolism in patients with cancer: from clinical trials to real life.
    Verso M; Agnelli G
    Thromb Res; 2020 Jul; 191 Suppl 1():S123-S127. PubMed ID: 32736770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bariatric venous thromboembolism prophylaxis: an update on the literature.
    Hamadi R; Marlow CF; Nassereddine S; Taher A; Finianos A
    Expert Rev Hematol; 2019 Sep; 12(9):763-771. PubMed ID: 31219356
    [No Abstract]   [Full Text] [Related]  

  • 27. DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines.
    Neumann I; Izcovich A; Zhang Y; Rada G; Kahn SR; Spencer F; Rezende S; Dentali F; Bauer K; Morgano GP; Yepes-Nuñez JJ; Nieuwlaat R; Wiercioch W; Lu L; Wu J; Cushman M; Schunemann H
    Blood Adv; 2020 Apr; 4(7):1512-1517. PubMed ID: 32289163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.
    Giustozzi M; Agnelli G; Del Toro-Cervera J; Klok FA; Rosovsky RP; Martin AC; Herold J; Tzoran I; Szmit S; Bertoletti L; Becattini C; Huisman MV
    Thromb Haemost; 2020 Jul; 120(7):1128-1136. PubMed ID: 32365386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Ross JA; Miller MM; Rojas Hernandez CM
    Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.
    Al-Hameed F; Al-Dorzi HM; AlMomen A; Algahtani F; AlZahrani H; AlSaleh K; AlSheef M; Owaidah T; Alhazzani W; Neumann I; Wiercioch W; Brozek J; Schünemann H; Akl EA
    Ann Saudi Med; 2015; 35(2):95-106. PubMed ID: 26336014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?
    Verso M; Franco L; Giustozzi M; Becattini C; Agnelli G
    Thromb Res; 2018 Apr; 164 Suppl 1():S168-S171. PubMed ID: 29703477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism.
    Zeng J; Zhang X; Lip GYH; Shu X; Thabane L; Tian J; Li G
    Clin Appl Thromb Hemost; 2019; 25():1076029619853629. PubMed ID: 31132874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Direct Oral Anticoagulants for Treating Venous Thromboembolism in Patients With Cancer.
    Soff GA
    J Natl Compr Canc Netw; 2018 May; 16(5S):670-673. PubMed ID: 29784753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient).
    Pernod G; Joly M; Sonnet B
    J Med Vasc; 2020 Nov; 45(6S):6S17-6S23. PubMed ID: 33276939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants.
    Posch F; Königsbrügge O; Zielinski C; Pabinger I; Ay C
    Thromb Res; 2015 Sep; 136(3):582-9. PubMed ID: 26210891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-molecular-weight heparin in oncology.
    Zacharski LR; Loynes JT
    Anticancer Res; 2003; 23(3C):2789-93. PubMed ID: 12926114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of direct oral anticoagulants in the treatment of acute venous thromboembolism in cancer patients.
    Abdel-Razeq H; Finianos A; Taher AT
    Expert Rev Hematol; 2018 Jun; 11(6):487-494. PubMed ID: 29791257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients.
    Song AB; Rosovsky RP; Connors JM; Al-Samkari H
    Vasc Health Risk Manag; 2019; 15():175-186. PubMed ID: 31417269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
    Farge D; Debourdeau P; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Bounameaux H; Büller HR
    J Thromb Haemost; 2013 Jan; 11(1):56-70. PubMed ID: 23217107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer and thrombosis: implications of published guidelines for clinical practice.
    Khorana AA
    Ann Oncol; 2009 Oct; 20(10):1619-30. PubMed ID: 19561038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.